Halozyme Therapeutics shares owned by Advisor Group Holdings
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Advisor Group Holdings
from 13F filings
Historical chart of Advisor Group Holdings investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Advisor Group Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $18M | 249k | 73.34 |
| 2025-06-30 | $2.1M | 37k | 55.24 |
| 2025-03-31 | $1.9M | 30k | 63.81 |
| 2024-12-31 | $599k | 11k | 53.83 |
| 2024-09-30 | $1.2M | 21k | 57.24 |
| 2024-03-31 | $354k | 8.7k | 40.69 |
| 2023-12-31 | $495k | 13k | 36.96 |
| 2023-09-30 | $747k | 20k | 38.21 |
| 2023-06-30 | $77k | 59k | 1.30 |
| 2023-03-31 | $475k | 12k | 38.19 |
| 2022-12-31 | $1.8M | 33k | 56.10 |
| 2022-09-30 | $1.2M | 30k | 40.06 |
| 2022-06-30 | $1.8M | 40k | 43.96 |
| 2022-03-31 | $563k | 14k | 39.84 |
| 2021-12-31 | $620k | 16k | 39.77 |
| 2021-09-30 | $1.0M | 26k | 39.57 |
| 2021-06-30 | $627k | 14k | 45.92 |
| 2021-03-31 | $539k | 13k | 40.82 |
| 2020-12-31 | $2.5M | 60k | 41.10 |
| 2020-09-30 | $398k | 11k | 37.04 |
| 2020-06-30 | $465k | 13k | 37.04 |
| 2020-03-31 | $0 | 8.2k | 0.00 |